Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
SELEGILINE HYDROCHLORIDE
Ceva Animal Health Limited
QN06A
SELEGILINE HYDROCHLORIDE
16.74 Milligram
Film Coated Tablet
POM
Canine
ANTIDEPRESSANTS
Neurological Preparations
Authorised
2002-11-22
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT SELGIAN 40kg, Film coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a 1020 mg tablet Active substance: Selegiline (as hydrochloride) 16.74 mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablet. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs (from 26 kg to 86 kg). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES - Treatment of behavioural disorders of purely emotional origin: depression, dysthymia, anxiety. - In combination with behaviour therapy, treatment of disorders of emotional origin found in hypersensibility/hyperactivity, separation anxiety, deprivation syndrome and generalised phobia. 4.3 CONTRAINDICATIONS Owing to its MAOI properties, selegiline may act on prolactin secretion. For want of specific studies, the product should not be administered to pregnant and lactating bitches. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES The use of a dosage less than the recommended dosage may result in exacerbation of the dog’s aggressiveness in case of latent hierarchy conflict. If no clinical improvement is observed after 2 months, it is useless to continue the treatment. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 28/11/2014_ _CRN 7019244_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Emotional disorders can mask hierarchical conflicts. In dominant dogs suffering from an emotional disorder, the alleviation of the disorder can sometimes reveal a latent aggressiveness. In such cases, behavioural therapy must be instituted. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT T Lue koko asiakirja